Antithrombotic Therapy for ACS in Elderly Patients

Area of Science:

• Cardiology
• Geriatric Medicine
• Internal Medicine

Background:

• Elderly patients (over 75) constitute a significant proportion of myocardial infarction cases and in-hospital mortality.
• There is a lack of specific clinical guidelines for managing acute coronary syndromes (ACS) in older adults.
• Older adults are often underrepresented in clinical trials, leading to limited evidence-based treatment data.

Purpose of the Study:

• To review current treatment strategies for ACS in elderly patients.
• To focus on the specific challenges and adaptations needed for antithrombotic therapy in this demographic.
• To synthesize data from pivotal trials and major guidelines (AHA/ACC, ESC).

Main Methods:

• Review of existing scientific literature and pivotal clinical trials.
• Analysis of current American Heart Association/American College of Cardiology (AHA/ACC) guidelines.
• Examination of European Society of Cardiology (ESC) guidelines.

Main Results:

• Antithrombotic therapy is generally effective and safe in elderly patients with ACS.
• Higher bleeding risk in the elderly is associated with comorbidities like renal impairment and malnutrition, necessitating specific precautions.
• Evidence for elderly patients in major trials is scarce, highlighting the need for adapted treatment approaches.

Conclusions:

• Antithrombotic therapy for ACS in the elderly must be adapted to mitigate bleeding risks without compromising efficacy.
• Close monitoring and individualized treatment adjustments are essential for this high-risk population.
• Further research focusing on elderly populations is needed to refine ACS management guidelines.